SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-312823
Filing Date
2019-12-12
Accepted
2019-12-12 16:56:19
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d839287ds3.htm S-3 151494
2 EX-5.1 d839287dex51.htm EX-5.1 8504
3 EX-23.1 d839287dex231.htm EX-23.1 1703
4 EX-23.2 d839287dex232.htm EX-23.2 2203
5 GRAPHIC g839287dsp24.jpg GRAPHIC 3215
6 GRAPHIC g839287g00w12.jpg GRAPHIC 32728
7 GRAPHIC g839287page23a.jpg GRAPHIC 3105
  Complete submission text file 0001193125-19-312823.txt   219048
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235475 | Film No.: 191282451
SIC: 2834 Pharmaceutical Preparations